A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization

Clinical trial NCT07088926 · RECRUITING

Trial details

NCT number: NCT07088926
Sponsor: AstraZeneca
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Bronchiectasis With Pseudomonas Aeruginosa Colonization

Start date: 2025-11-06
Primary completion: 2027-12-09
Enrollment: 435

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.